Extraskeletal Myxoid Chondrosarcoma clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma
open to eligible people ages 18 years and up
This phase II trial compares the effect of immunotherapy with ipilimumab and nivolumab alone to their combination with cabozantinib in treating patients with soft tissue sarcoma that has spread from where it first started to nearby tissue, lymph…
Irvine, California and other locations
Our lead scientists for Extraskeletal Myxoid Chondrosarcoma research studies include Warren A. Chow.
Last updated: